✦ LIBER ✦

Long-term anti–tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion

✍ Scribed by Rainer H. Straub; Georg Pongratz; Jürgen Schölmerich; Frieder Kees; Thomas F. Schaible; Christian Antoni; Joachim R. Kalden; Hanns-Martin Lorenz

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 161 KB
Volume: 48
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.11036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti–interleukin-6 receptor antibody the

Anti–interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled study

✍ Rainer H. Straub; Peter Härle; Seizo Yamana; Takemasa Matsuda; Kiyoshi Takasugi; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 2 views

Active but transient improvement of endo

Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor α antibody

✍ Gonzalez-Juanatey, Carlos ;Testa, Ana ;Garcia-Castelo, Alberto ;Garcia-Porrua, C 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

## Abstract ## Objective Cardiovascular disease is the major cause of excessive mortality in rheumatoid arthritis (RA). Atherosclerosis and RA share similar inflammatory mechanisms that include involvement of tumor necrosis factor α (TNFα). Anti‐TNFα antibody improved endothelial function in RA pa